Literature DB >> 384325

Analgesia for operative dentistry: a comparison of acupuncture and placebo.

H A Taub, J N Mitchell, F E Stuber, L Eisenberg, M C Beard, R K McCormack.   

Abstract

Fifty-one volunteer patients participated in a study to evaluate the effectiveness of acupuncture as an analgesic for operative dentistry. For the twenty-six patients randomly assigned to an acupuncture group, needles were inserted through specially designed holders into the Ho-Ku points, located between the first and second metacarpals. An acupuncture pulse generator provided electrical current. For the twenty-five patients in a placebo group, the identical needle and holder arrangement was used. When inserted, however, the needles became embedded in plastic on the undersurface of the holders and did not touch the skin of the patient or receive any electrical stimulation. The patients and dentists were blind to this procedural variation. Analysis of ratings and responses indicated no differences in findings for the acupuncture and placebo procedures, with both having 100% success and high levels of patient acceptance. Since there was no electric current or penetration of the skin in the placebo group, the findings suggest that the successful use of acupuncture for restorative dentistry may be due to psychological and/or placebo effects in combination with a possible diminished need for analgesia because of the modern use of the high-speed drill.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 384325     DOI: 10.1016/0030-4220(79)90003-3

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  2 in total

1.  Integrating behavioral and pharmacological therapeutic modalities.

Authors:  S F Dworkin
Journal:  Anesth Prog       Date:  1986 Jan-Feb

2.  The Clinical Effect of Acupuncture in the Treatment of Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Zheng-Tao Lv; Wen-Xiu Jiang; Jun-Ming Huang; Jin-Ming Zhang; An-Min Chen
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-04       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.